Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Plasmodium vivax relapse infections occur following activation of latent liver-stages parasites (hypnozoites) causing new blood-stage infections weeks to months after the initial infection. We develop a within-host mathematical model of liver-stage hypnozoites, and validate it against data from tropical strains of P. vivax. The within-host model is embedded in a P. vivax transmission model to demonstrate the build-up of the hypnozoite reservoir following new infections and its depletion through hypnozoite activation and death. The hypnozoite reservoir is predicted to be over-dispersed with many individuals having few or no hypnozoites, and some having intensely infected livers. Individuals with more hypnozoites are predicted to experience more relapses and contribute more to onwards P. vivax transmission. Incorporating hypnozoite killing drugs such as primaquine into first-line treatment regimens is predicted to cause substantial reductions in P. vivax transmission as individuals with the most hypnozoites are more likely to relapse and be targeted for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“because reducing the substantial burden of vivax malaria requires attacking its hypnozoite reservoir with PQ or TQ; indeed, hypnozoites are the dominant (>80%) source of recurrent vivax infections (relapses)[15].”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205 · cited 1×
“Testing the hypothesis of constant activation would require follow up of patients treated with rapidly eliminated artemisinin monotherapy, a challenging proposition given the concerns over artemisinin resistant P. falciparum (Ashley et al., 2014).”
BackgroundRoss, Macdonald, and a Theory for the Dynamics and Control of Mosquito-Transmitted Pathogens
Smith, D. L., Battle, K. E., Hay, S. I., Barker, C. M., Scott, T. W., & McKenzie, F. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002588 · Cited by 631
Self-citationFate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., & Willenbring, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59261 · Cited by 434
The entomological inoculation rate and Plasmodium falciparum infection in African children
Smith, D. L., Dushoff, J., Snow, R. W., & Hay, S. I. (2005) · Nature · doi:10.1038/nature04024 · Cited by 369
Self-citationKelly-Hope, L. A., & McKenzie, F. E. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-19 · Cited by 203 · cited 2×
“239 vivax hypnozoite rate, these quantities can be measured in epidemiological field studies (31, 32).”
Background
Research works printed but not linked: 51
- Battle, 2014, Geographical variation in Plasmodium vivax relapse, Malaria Journal, 13, 144, 10.1186/1475-2875-13-144 · DOI · Paper page
- Beier, 1991, Quantitation of Plasmodium-falciparum sporozoites transmitted invitro by experimentally infected Anopheles-gambiae and Anopheles-stephensi, The American Journal of Tropical Medicine and Hygiene, 44, 564, 10.4269/ajtmh.1991.44.564 · DOI
- Berliner, 1948, Studies on the chemotherapy of the human malarias. vii. the antimalarial activity of pamaquine, The Journal of Clinical Investigation, 27, 108, 10.1172/JCI101947 · doi:10.1172/jci101947
- Betuela, 2012, Relapses contribute significantly to the risk of P. vivax infection and disease in Papua New Guinean children 1-5 years of age, The Journal of Infectious Diseases, 206, 1771, 10.1093/infdis/jis580 · DOI · Paper page
- Bharti, 2006, Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon, The American Journal of Tropical Medicine and Hygiene, 75, 610, 10.4269/ajtmh.2006.75.610 · DOI
- Chamchod, 2013, Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency, Journal of Theoretical Biology, 7, 25, 10.1016/j.jtbi.2012.08.024 · DOI
- Coatney, 1950, Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax, Journal of the National Malaria Society, 9, 381
- Collins, 2003, A retrospective examination of anemia during infection of humans with Plasmodium vivax, The American Journal of Tropical Medicine and Hygiene, 68, 410, 10.4269/ajtmh.2003.68.410 · DOI
- Coura, 2006, A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection - a review, Memorias Do Instituto Oswaldo Cruz, 101, 229, 10.1590/S0074-02762006000300001 · DOI · Paper page
- Dezoysa, 1991, A mathematical model for Plasmodium vivax malaria transmission - estimation of the impact of transmission-blocking immunity in an endemic area, Bulletin of the World Health Organization, 69, 725
- Dietz, 1973, A malaria model tested in the African savannah, Ninth International Congress on Tropical Medicine and Malaria Athens Volume 1 Abstracts of Invited Papers, 297
- Douglas, 2010, Artemisinin combination therapy for vivax malaria, The Lancet Infectious Diseases, 10, 405, 10.1016/S1473-3099(10)70079-7 · DOI · Paper page
- Douglas, 2011, Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics, Clinical Infectious Diseases, 52, 612, 10.1093/cid/ciq249 · DOI · Paper page
- Garrett-Jones, 1964, The human blood index of malaria vectors in relation to epidemiological assessment, Bulletin of the World Health Organization, 30, 241
- Gething, 2012, A long neglected world malaria map: Plasmodium vivax endemicity in 2010, PLOS Neglected Tropical Diseases, 6, e1814, 10.1371/journal.pntd.0001814 · DOI · Paper page
- Gething, 2011a, A new world malaria map: Plasmodium falciparum endemicity in 2010, Malaria Journal, 10, 378, 10.1186/1475-2875-10-378 · DOI · Paper page
- Gething, 2011b, Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax, Parasites and Vectors, 4, 92, 10.1186/1756-3305-4-92 · DOI · Paper page
- Hankey, 1953, Korean vivax malaria. I. Natural history and response to chloroquine, The American Journal of Tropical Medicine and Hygiene, 2, 958, 10.4269/ajtmh.1953.2.958 · doi:10.4269/ajtmh.1953.2.958
- Harris, 2010, A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting, Malaria Journal, 9, 254, 10.1186/1475-2875-9-254 · DOI · Paper page
- Horing, 1947, Induced and war malaria, The Journal of Tropical Medicine and Hygiene, 50, 150
- Howes, 2013, G6PD deficiency: global distribution, genetic variants and primaquine therapy, Advances in Parasitology, 81, 133, 10.1016/B978-0-12-407826-0.00004-7 · DOI · Paper page
- Hulden, 2011, Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival, Malaria Journal, 10, 90, 10.1186/1475-2875-10-90 · DOI
- Ishikawa, 2003, A mathematical model for the transmission of Plasmodium vivax malaria, Parasitology International, 52, 81, 10.1016/S1383-5769(02)00084-3 · doi:10.1016/s1383-5769(02)00084-3
- Kim, 2011, Performance of the CareStart (TM) G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening, PLOS ONE, 6, e28357, 10.1371/journal.pone.0028357 · DOI · Paper page
- Koepfli, 2011, Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea, PLOS Neglected Tropical Diseases, 5, e1424, 10.1371/journal.pntd.0001424 · doi:10.1371/journal.pntd.0001424
- Koepfli, 2013, A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean children, PLOS Neglected Tropical Diseases, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
- Llanos-Cuentas, 2014, Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study, Lancet, 383, 1049, 10.1016/S0140-6736(13)62568-4 · DOI · Paper page
- Lover, 2013, Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria, Emerging Infectious Diseases, 19, 1058, 10.3201/eid1907.121674 · doi:10.3201/eid1907.121674
- Lover, 2014, The distribution of incubation and relapse times in experimental human infections with the malaria parasite Plasmodium vivax, BMC Infectious Diseases, 14, 539, 10.1186/1471-2334-14-539 · DOI
- Macdonald, 1952a, The analysis of equilibrium in malaria, Tropical Diseases Bulletin, 49, 813
- Macdonald, 1952b, The analysis of the sporozoite rate, Tropical Diseases Bulletin, 49, 569
- malERA Consultative Group on Diagnoses and Diagnostics, 2011, A research agenda for malaria eradication: diagnoses and diagnostics, PLOS Medicine, 8, e1000396, 10.1371/journal.pmed.1000396 · DOI · Paper page
- malERA Consultative Group on Modeling, 2011, A research agenda for malaria eradication: modeling, PLOS Medicine, 8, e1000403, 10.1371/journal.pmed.1000403 · DOI · Paper page
- Medica, 2005, Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected Anopheline mosquitoes, Infection and Immunity, 73, 4363, 10.1128/IAI.73.7.4363-4369.2005 · DOI · Paper page
- Molineaux, 2001, Plasmodium falciparum parasitaemia described by a new mathematical model, Parasitology, 122, 379, 10.1017/S0031182001007533 · DOI
- Mueller, 2009a, Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite, The Lancet Infectious Diseases, 9, 555, 10.1016/S1473-3099(09)70177-X · DOI · Paper page
- Mueller, 2013, Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets, Advances in Parasitology, 81, 77, 10.1016/B978-0-12-407826-0.00003-5 · DOI
- Mueller, 2009b, High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea, Malaria Journal, 8, 41, 10.1186/1475-2875-8-41 · DOI
- Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, The Lancet Infectious Diseases, 14, 982, 10.1016/S1473-3099 · doi:10.1016/s1473-3099
- Reiner, 2013, A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010, Journal of the Royal Society, Interface, 10, 20120921, 10.1098/rsif.2012.0921 · DOI · Paper page
- Roy, 2013, The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India, PLOS Neglected Tropical Diseases, 7, e1979, 10.1371/journal.pntd.0001979 · DOI
- Sattabongkot, 2004, Plasmodium vivax transmission: chances for control?, Trends in Parasitology, 20, 192, 10.1016/j.pt.2004.02.001 · DOI
- Shanks, 2013, The activation of vivax malaria hypnozoites by infectious diseases, The Lancet Infectious Diseases, 13, 900, 10.1016/S1473-3099(13)70095-1 · doi:10.1016/s1473-3099(13)70095-1
- Smith, 2010, A quantitative analysis of transmission efficiency versus intensity for malaria, Nature Communications, 1, 108, 10.1038/ncomms1107 · DOI · Paper page
- Smith, 2014, Recasting the theory of mosquito-borne pathogen transmission dynamics and control, Transactions of the Royal Society of Tropical Medicine and Hygiene, 108, 185, 10.1093/trstmh/tru026 · DOI · Paper page
- Snounou, 2004, The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand, Trends in Parasitology, 20, 333, 10.1016/j.pt.2004.05.004 · DOI
- Tarning, 2014, Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with Plasmodium vivax malaria in Thailand, CPT: Pharmacometrics & Systems Pharmacology, 3, e132, 10.1038/psp.2014.29 · DOI
- Wearing, 2005, Appropriate models for the management of infectious diseases, PLOS Medicine, 2, e174, 10.1371/journal.pmed.0020174 · DOI · Paper page
- Wells, 2010, Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination, Trends in Parasitology, 26, 145, 10.1016/j.pt.2009.12.005 · DOI · Paper page
- White, 2013, The relationship between RTS, S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection, PLOS ONE, 8, e61395, 10.1371/journal.pone.0061395 · DOI · Paper page
- White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malaria Journal, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
Cited by
Global Epidemiology of Plasmodium vivax
Howes, R. E., Battle, K. E., Mendis, K. N., Smith, D. L., Cibulskis, R. E., Baird, J. K., & Hay, S. I. (2016) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0141 · Cited by 418
Self-citationRobinson, L. J., Wampfler, R., Betuela, I., Karl, S., White, M. T., Li Wai Suen, C. S. N., Hofmann, N. E., Kinboro, B., Waltmann, A., Brewster, J., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001891 · Cited by 276
Self-citationTaylor, W. R. J., Kim, S., Kheng, S., Muth, S., Tor, P., Christophel, E., Mukaka, M., Kerleguer, A., Luzzatto, L., Baird, J. K., et al. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009690 · Cited by 9
Metadata
- Authors
- White, M. T., Karl, S., Battle, K. E., Hay, S. I., Mueller, I., & Ghani, A. C.
- Affiliations
- MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
- Department of Infection and Immunity, Walter and Eliza Hall Institute, Melbourne, Australia
- Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford, United Kingdom
- ORCID
- Hay, Simon I
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2014-11-18
- Volume
- 3
- ISSN
- 2050-084X
- Cited by
- 111
- References
- 5
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- Medical Research Council (Population Health Scientist Fellowship)
- National Health and Medical Research Council (Senior Research Fellowship, Research Fellowship)
- Wellcome Trust (Senior Research Fellowship)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.